Senior insider sale
SVP and CMO at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$25.7K
4.95K shares
What this filing means
RAJAH VIGNESH plans to sell 4.95K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $25.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/7/2025ACC: 0001964306-25-000144
Officer· SVP and CMO
Since Jun 2020
4.95K
Shares to sell
$25.7K
Approx. market value
4.95K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/18/2025
2.47KVesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2025
2.47KTotal acquired4.95K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/18/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.47K | — |
1/17/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.47K | — |
| Total | 4.95K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.95K
Market value
$25.7K
3/7/2025
Total
Units
4.95K
Value
$25.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/7/2025 | 4.95K | $25.7K | NASDAQ | Planned |
| Total | 4.95K | $25.7K | ||